Saint Vincent and the Grenadines vs Sur: Measles-containing-vaccine second-dose (MCV2) immunization coverage
Saint Vincent and the Grenadines
99.0%
in 2025
Sur
52.0%
in 2025
Saint Vincent and the Grenadines rank
1st
Sur rank
2nd
Measles-containing-vaccine second-dose (MCV2) immunization coverage over time
- Saint Vincent and the Grenadines
- Sur
How they compare
Saint Vincent and the Grenadines currently reports 99.0% against 52.0% in Sur, a difference of 47.0%.
That makes Saint Vincent and the Grenadines's figure about 1.9 times Sur's.
The two have swapped places 1 time across 26 shared years of data; in 2000 it was Sur ahead.
Saint Vincent and the Grenadines ranks 1st and Sur ranks 2nd of 194 countries.
Saint Vincent and the Grenadines has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Saint Vincent and the Grenadines | Sur | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 80.9% | 0.0% | 80.9% | Saint Vincent and the Grenadines |
| 2010s | 96.1% | 18.0% | 78.1% | Saint Vincent and the Grenadines |
| 2020s | 97.0% | 45.7% | 51.3% | Saint Vincent and the Grenadines |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher measles-containing-vaccine second-dose (mcv2) immunization coverage, Saint Vincent and the Grenadines or Sur?
- Saint Vincent and the Grenadines, at 99.0% against 52.0% in Sur as of 2025.
- What is the difference in measles-containing-vaccine second-dose (mcv2) immunization coverage between Saint Vincent and the Grenadines and Sur?
- 47.0%, with Saint Vincent and the Grenadines ahead.
- How many years of comparable data are there for Saint Vincent and the Grenadines and Sur?
- 26 years are reported by both, from 2000 to 2025.
- How do Saint Vincent and the Grenadines and Sur rank globally for measles-containing-vaccine second-dose (mcv2) immunization coverage?
- Saint Vincent and the Grenadines ranks 1st and Sur ranks 2nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Measles-containing-vaccine second-dose (MCV2) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.